arrow
E

Esther H. Lips

netherlands cancer institute
H指数:41
被引数:6,036

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Risk stratification and relapse pattern in triple-negative breast cancer with pathological complete response after neoadjuvant treatment: the European GAMBIT real-world study
2026-06-240
OAAI
High-depth whole genome sequencing of premalignant breast lesions reveals rearrangement hotspots and personalized management opportunities

高危癌前乳腺癌病变的高深度全基因组测序揭示重排热点及个性化管理机会

2026-05-190
OAAI
Development and internal validation of mammography feature-based prognostic models for distant recurrence-free survival of invasive breast cancer in a screening cohort

基于乳腺X光特征的发展与内部验证:筛查队列中浸润性乳腺癌远处复发无进展生存的预后模型

2026-04-200
OAAI
Development of radiomics-based models on mammograms with mass lesions to predict prognostically relevant characteristics of invasive breast cancer in a screening cohort: Epidemiology

基于乳腺X线影像中肿块病变的放射组学模型开发,用于预测筛查队列中浸润性乳腺癌的预后相关特征:流行病学

2025-04-060
PRE
PROACTING: predicting pathological complete response to neoadjuvant chemotherapy in breast cancer from routine diagnostic histopathology biopsies with deep learning

通过深度学习预测常规诊断组织病理学活检对乳腺癌新辅助化疗的病理完全反应

2023-11-134
OAAI
Association of DCIS size and margin status with risk of developing breast cancer post-treatment: multinational, pooled cohort study
2023-10-306
OAAI
High-dose alkylating chemotherapy in BRCA-altered triple-negative breast cancer: the randomized phase III NeoTN trial
2023-09-093
OA